◑ We're currently building out coverage for Swiss-listed stocks (SIX Swiss Exchange). Other markets will follow.

PolyPeptide Group AG

CH1110760852 · PPGNSIX ·

CH · Healthcare · Stock

PolyPeptide Group AG is a Swiss-based contract development and manufacturing organization (CDMO) specializing in the production of peptide active pharmaceutical ingredients for the global pharmaceutical and biotechnology industry. The company operates multiple GMP-certified manufacturing facilities across Europe and North America, serving a broad range of innovator and generic drug customers. Listed on the SIX Swiss Exchange, PolyPeptide focuses exclusively on peptide synthesis, making it one of the largest independent peptide CDMOs in the world.

Dividend Yield

1.34%

TTM · SIX

Last Dividend

0.30

CHF · 2022-04-28

5Y Growth

—

CAGR

Frequency

None

Years Paid

consecutive

Not Cut

—

consecutive yrs

Grown

—

consecutive yrs

Listings

Exchange	Ticker	Currency	Yield TTM
SIX primary	PPGN	CHF	1.34%

Total Return

Starting Amount 10'000 CHF

Price Gain +7'023 CHF

Dividends —

Total Return +70.23%

CAGR +70.30%

End Balance 17'023 CHF

Based on 10,000 invested at the start of the period. Price return uses split-adjusted closing prices. Dividends are not reinvested.

Annual Dividends

2022 CHF 0.30

2022

Annual dividend per share · 1 years of data

Dividend Yield History

Loading yield history…

ⓘ

Dividend History

Ex-Date ▼	Pay-Date ▼	Amount ▼	Type ▼
28.04.2022	02.05.2022	0.30 CHF	Ordinary